Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow mesenchymal stem cells plus biomaterial versus iliac crest autologous graft for long-bone non-union
2015-000431-32Phase 3Active
- Sponsor
- Universidad Autónoma de Madrid
- Start
- May 2017
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous bone marrow derived mesenchymal stromal cells in fracture nonunion (3 arms), sponsored by Universidad Autónoma de Madrid. Primary endpoint: Bone consolidation at 12 months. Started May 2017; status: active.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
fracture nonunion
Beyond the preview
Go deeper on 2015-000431-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000431-32.